Treatment of depression: Time to consider folic acid and vitamin B 12

Journal of Psychopharmacology

Volumn 19, Issue 1, 2005, Pages 59-65

  Coppen, Alec ^a,b   Bolander Gouaille, Christina ^b  

^a MRC Neuropsychiatry Research Laboratory   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Cobalamin; Depression; Diet; Folate; Folic acid; Homocysteine; One carbon metabolism; S adenosylmethionine; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; NORTRIPTYLINE; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; DEPRESSION; DRUG ERYTHROCYTE LEVEL; ENZYME POLYMORPHISM; FOLATE METABOLISM; GENETIC RISK; HUMAN; HYPERHOMOCYSTEINEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

BRAIN; DEPRESSIVE DISORDER, MAJOR; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NUTRITIONAL STATUS; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 12444279964     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105048899     Document Type: Review

References (63)

1. Abou-Saleh M T, Coppen A (1986) The biology of folate in depression; implications for the nutritional hypotheses of the psychoses. J Psychiatr Res 20: 91-101
2. Abou-Saleh M T, Coppen A (1988) Continuation therapy with antidepressants after electroconvulsive therapy. Convuls Ther 4: 263-268
3. Abou-Saleh M T, Coppen A (1989) Serum and red blood cell folate in depression, Acta Psychiatr Scand 80: 78-82
4. Agency for Health Care Policy and Research (1999) Treatment of depression - newer pharmacotherapies. Summary, Evidence Report/Technology Assessment: Number 7. http://www.ahcpr.gov/clinic/deprsumm.htm
5. Alpert J E, Mischoulon D, Nierenberg A, Fava M (2000) Nutrition and depression: focus on folate. Nutrition 16: 544-546
6. Alpert J E, Mischoulon D, Rubenstein G E, Bottonari K, Nierenberg A A, Fava M (2002) Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatr 14: 33-38
7. Alpert M, Silva R R, Pouget E R (2003) Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol 23: 309-313
8. Angst J, Gamma A, Sellaro R, Lavori P W, Zhang H (2003) Recurrence of bipolar disorders and major depression, 'a lifelong perspective'. Eur Arch Psychiatr Clin Neurosci 253: 236-240
9. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M (1997) Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74: 526-528
10. Barraclough B, Bunch J, Nelson B, Sainsbury P (1974) A hundred cases of suicide: clinical aspects. Br J Psychiatry 125: 355-373
11. 12, homocysteine, and the MTHFR 677C>T polymorphism in anxiety and depression. Arch Gen Psychiatry 60: 618-626
12. Bolander-Gouaille C, Bottiglieri T (2003) Homocysteine, Related Vitamins and Neuropsychiatric Disorders. Springer, Paris
13. Botez M I, Young S N, Bachevalier J, Gauthier S (1979) Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature 278: 182-183
14. 12 deficiencies on 5-hydoxyindoleacetic acid in human cerebrospinal fluid. Ann Neurol 12: 479-484
15. Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MWP, Toone B K, Reynolds R H (1992) Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med 22: 871-876
16. Bottiglieri T, Laundy M, Crellin R, Toone B K, Carney MWP, Reynolds E H (2000) Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurosurg Psychiatry 69: 228-232
17. Candito M, Aubin-Brunet V, Beaulieu F, Chevalier T, Pringuey D, Darcourt G (1997) Increased postprandial homocysteinemia in a group of depressed patients. Amino Acids 12: 315-321
18. 12 in psychiatric in-patients. Psychol Med 8: 139-144
19. Carney M W P, Chary T K N, Laundy M, Bottiglieri T, Chanarin I, Reynolds R H, Toone B (1990) Red cell folate concentrations in psychiatric patients. J Affect Disord 19: 207-213
20. Chen C N, Wong J, Lee N, Chan-Ho M W, Lau J T F, Fung M (1993) The Shatin Community Mental Health Survey in Hong Kong. Arch Gen Psychiatry 50: 125-133
21. Coppen A, Bailey J (2000) Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 60: 121-130
22. Coppen A, Abou-Saleh M T, Milln P, Bailey J, Metcalfe M, Burns B H, Armond A (1981) Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 139: 284-287
23. Coppen A, Abou-Saleh M T (1982) Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry 141: 87-89
24. Coppen A, Chaudry S, Swade C (1986) Folic acid enhances lithium prophylaxis. J Affect Disord 10: 9-13
25. Coppen A, Swade C, Jones S A, Armstrong R A, Blair J A, Leeming RJ (1989) Depression and tetrahydrobiopterin: the folate connection. J Affect Disord 16: 103-107
26. De Bree A, Verschuren M M, Kromhout D, Kluijtmans LAJ, Blom H J (2002) Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 54: 599-618
27. Di Rocco A, Rogers J D, Brown R, Werner P, Bottiglieri T (2000) S-Adenosylmethionine improves depression in patients with Parkinson's disease in an open-label clinical trial. Mov Disord 15: 1225-1229
28. Edeh J, Toone B K (1985) Antiepileptic therapy, folate deficiency, and psychiatric morbidity: a general practice survey. Epilepsia 26: 434-440
29. 12 and homocysteine in major depressive disorder. Am J Psychiatry 154: 426-28
30. Geddes J R, Carney S M, Davies C, Furukawa T A, Kupfer D J, Frank E, Goodwin G M (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361: 653-661
31. Glassman A H, Shapiro P A (1998) Depression and the cause of coronary artery disease. Am J Psychiatry 55: 4-11
32. Godfrey P S, Toone B K, Carney M W, Flynn T G, Bottiglieri T, Laundy M, Chanarin I, Reynolds E H (1990) Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336: 392-395
33. Gottfries C G (2001) Late life depression. Eur Arch Psychiatry Clin Neurosci 251 (Suppl 2): II57-II61
34. Hickie I, Scott E, Naismith S, Ward P B, Turner K, Parker G, Mitchell P, Wilhelm K (2001) Late-onset depression: genetic, vascular and clinical contributions. Psychological Med 31: 1403-1412
35. 12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry 3: 17. Available at www.biomedcentral.com/ 1471-244X/3117
36. Homocysteine Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplement: metanalysis of randomised trials. Br Med J 316: 894-898
37. Isacsson G (2000) Suicide prevention - a medical breakthrough? Acta Psychiatr Scand 102: 113-117
38. Janicak P G, Davis J M, Gibbons R D, Ericsen S, Chang S, Gallghar P (1985) Efficacy of ECT: a meta-analysis. Am J Psychiatry 142: 297-302
39. Lee S, Chow C C, Shek C C, Wing Y K, Chen C N (1992) Folate concentration in Chinese psychiatric outpatients on long-term lithium treatment. J Affect Disord 24: 265-270
40. Lee S, Wing Y K, Fong S (1998) A controlled study of folate levels in Chinese inpatients with major depression in Hong Kong. J Affect Diosord 49: 73-77
41. Levitt A J, Wesson V A, Joffe R T (1998) Impact of suppression of thyroxine on folate status during antidepressant therapy. Psychiatry Res 79: 123-129
42. 12. Lancet360: 174-175
43. Merry J. Abou-Saleh M, Coppen A (1982) Alcoholism, depression and plasma folate. Br J Psychiatry 141: 103-104
44. Mischoulon D, Fava M (2002) Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 76: 1158S-1161S
45. Morris M S, Fava M, Jacques P F, Selhub J, Rosenberg I H (2003) Depression and folate status in the US population. Psychother Psychosom 72: 59-60
46. Murray C J. Lopez A D (1997) Global Mortality, Disability, and the contribution of risk factors: global burden of disease study. Lancet 349: 1436-1442
47. Pancheri P, Scapicchio P, DelleChiaie R D (2002) A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate versus imipramine in patients with major depressive disorder. Int J Neuropsychopharmacol 5: 287-294
48. Papakostas G I, Alpert J E, Fava M (2003) S-adenosyl-methionine in depression: a comprehensive review of the literature. Curr Psychiatry Rep 5: 460-466
49. Passeri M, Cucinotta D, Abate G, Senin U, Ventura A, Stramba Badiale M, Diana R, La Greca P, Le Grazie C (1993) Oral 5-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter trial. Ageing 5: 63-71
50. 12 deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's health and Aging Study. Am J Psychiatry 157: 715-721
51. Procter A (1991) Enhancement of recovery from psychiatric illness by methylfolate. Br J Psychiatry 159: 271-272
52. Refsum H, Smith A D, Ueland P M, Nexö E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, NcPartlin C, Scott J M (2004) Facts and Recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50: 3-32
53. Reynolds E H, Preece J M, Bailey J, Coppen A (1970) Folate deficiency in depressive illness. Br J Psychiatry 117: 287-292
54. Reynolds E H (2002) Folic acid, ageing, depression and dementia. Br Med J 324: 1512-1515
55. Rosche J, Uhlman C, Froscher W (2003) Low serum folate levels as a risk faetor for depressive mood in patients with chronic epilepsy. J Neuropsychiatry Clin Neurosci 15: 64-66
56. Shorvon S, Carney M W P, Chanarin I, Reynolds E (1980) The neuropsychiatry of megaloblastic anaemia. Br Med J 281: 1036-1038
57. Taylor M J, Carney S, Geddes J, Goodwin G (2004) Folate for depressive disorders. J Psychopharmacol 18: 251-256
58. 12, folate. and homocysteine in depression: the Rotterdam study. Am J Psychiatry 159: 2099-2101
59. Tolmunen T, Voutilainen S, Hintikka J, Rissanen T, Tanskanen A, Viinamäki H, Kaplan G A. Salonen J T (2003) Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 133: 3233-3236
60. van Amsterdam G J, Oppenhuizen A (1999) Nitric oxide and biopterin in depression and stress. Psychiatry Res 85: 33-38
61. Wald D S, Bishop L, Wald N J, Law M, Hennessy E, Weir D, McPartlin J, Scott J (2001) Randomized trial of folic acid supplemen-tation and serum homocysteine levels. Arch Intern Med 161: 695-700
62. Weissman M M, Bland R C, Canino G J, Faravelli C, Greenwald S, Hwu H G, Joyce P R, Karam E G, Lee C K, Lellouch J, Lépine J P, Newman S C, Rubic-Stipec M, Wells J E, Wickramaratne P J, Wittchen H U, Yeh E K (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293-299
63. Wesson V A, Levitt A J, Joffe R T (1994) Change in folate status with antidepressive treatment. Psychiatry Res 53: 313-322